Vanguard Group’s Reviva Pharmaceuticals RVPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $687K | Hold |
1,804,092
| – | – | ﹤0.01% | 3849 |
|
|
2025
Q1 | $1.72M | Buy |
1,804,092
+419,500
| +30% | +$400K | ﹤0.01% | 3540 |
|
|
2024
Q4 | $2.51M | Buy |
1,384,592
+359,343
| +35% | +$650K | ﹤0.01% | 3493 |
|
|
2024
Q3 | $1.48M | Hold |
1,025,249
| – | – | ﹤0.01% | 3653 |
|
|
2024
Q2 | $1.31M | Buy |
1,025,249
+23,413
| +2% | +$30K | ﹤0.01% | 3700 |
|
|
2024
Q1 | $3.79M | Buy |
1,001,836
+26,854
| +3% | +$102K | ﹤0.01% | 3401 |
|
|
2023
Q4 | $5.02M | Buy |
974,982
+359,050
| +58% | +$1.85M | ﹤0.01% | 3288 |
|
|
2023
Q3 | $3.01M | Hold |
615,932
| – | – | ﹤0.01% | 3456 |
|
|
2023
Q2 | $3.61M | Buy |
615,932
+42,162
| +7% | +$247K | ﹤0.01% | 3453 |
|
|
2023
Q1 | $2.4M | Buy |
573,770
+107,353
| +23% | +$450K | ﹤0.01% | 3609 |
|
|
2022
Q4 | $1.98M | Buy |
466,417
+60,023
| +15% | +$255K | ﹤0.01% | 3655 |
|
|
2022
Q3 | $646K | Sell |
406,394
-58,414
| -13% | -$92.9K | ﹤0.01% | 4149 |
|
|
2022
Q2 | $511K | Sell |
464,808
-700
| -0.2% | -$770 | ﹤0.01% | 4289 |
|
|
2022
Q1 | $1.15M | Sell |
465,508
-28,900
| -6% | -$71.1K | ﹤0.01% | 4164 |
|
|
2021
Q4 | $1.43M | Sell |
494,408
-14,648
| -3% | -$42.3K | ﹤0.01% | 4158 |
|
|
2021
Q3 | $2.07M | Sell |
509,056
-20,408
| -4% | -$83.1K | ﹤0.01% | 4049 |
|
|
2021
Q2 | $2.57M | Buy |
+529,464
| New | +$2.57M | ﹤0.01% | 3896 |
|